Cargando…

Provider and user acceptability of intermittent screening and treatment for the control of malaria in pregnancy in Malawi

BACKGROUND: Malaria in pregnancy is a major cause of adverse maternal and fetal outcomes. Intermittent preventive treatment with sulfadoxine–pyrimethamine (IPTp-SP) is one of the control strategies promoted by WHO. In response to mounting resistance to SP, intermittent screening and treatment (ISTp)...

Descripción completa

Detalles Bibliográficos
Autores principales: Almond, Deborah, Madanitsa, Mwayi, Mwapasa, Victor, Kalilani-Phiri, Linda, Webster, Jayne, ter Kuile, Feiko, Paintain, Lucy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5126811/
https://www.ncbi.nlm.nih.gov/pubmed/27894353
http://dx.doi.org/10.1186/s12936-016-1627-5
_version_ 1782470173476782080
author Almond, Deborah
Madanitsa, Mwayi
Mwapasa, Victor
Kalilani-Phiri, Linda
Webster, Jayne
ter Kuile, Feiko
Paintain, Lucy
author_facet Almond, Deborah
Madanitsa, Mwayi
Mwapasa, Victor
Kalilani-Phiri, Linda
Webster, Jayne
ter Kuile, Feiko
Paintain, Lucy
author_sort Almond, Deborah
collection PubMed
description BACKGROUND: Malaria in pregnancy is a major cause of adverse maternal and fetal outcomes. Intermittent preventive treatment with sulfadoxine–pyrimethamine (IPTp-SP) is one of the control strategies promoted by WHO. In response to mounting resistance to SP, intermittent screening and treatment (ISTp) has been proposed as an alternative. The objective of this study was to explore the acceptability of ISTp for health workers and pregnant women. METHODS: Semi-structured interviews of ten health workers and five focus group discussions of 38 women enrolled in an ongoing trial comparing IPTp-SP and ISTp with dihydroartemisinin–piperaquine (DP) were conducted at two antenatal clinics in rural Malawi. All transcripts were coded and themes were identified using a content analysis approach. RESULTS: Amongst health workers, there were contrasting opinions on the preference of blood sampling methods, and the influence of method on reliability of diagnosis. The perceived greater effectiveness of DP compared to SP was appreciated, however concerns of user compliance with the full dose of DP in non-trial settings were raised. Despite the discomfort of repeated finger pricks, pregnant women were generally accepting of ISTp, particularly the chance for regular blood tests to check for infections and the perceived greater effectiveness with fewer side effects of DP compared to SP. CONCLUSION: In the trial context, pregnant women tended to prefer ISTp-DP over IPTp-SP. Health workers were also accepting of ISTp-DP as an alternative to IPTp-SP in light of increasing SP resistance. However, reliability of stock, adherence to malaria test results and user adherence to the full course of DP may present barriers to successful routine implementation. Effective communication with health workers and between health workers, pregnant women and their communities will be essential for the acceptability of focused antenatal care, including the best malaria control measures available.
format Online
Article
Text
id pubmed-5126811
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-51268112016-12-08 Provider and user acceptability of intermittent screening and treatment for the control of malaria in pregnancy in Malawi Almond, Deborah Madanitsa, Mwayi Mwapasa, Victor Kalilani-Phiri, Linda Webster, Jayne ter Kuile, Feiko Paintain, Lucy Malar J Research BACKGROUND: Malaria in pregnancy is a major cause of adverse maternal and fetal outcomes. Intermittent preventive treatment with sulfadoxine–pyrimethamine (IPTp-SP) is one of the control strategies promoted by WHO. In response to mounting resistance to SP, intermittent screening and treatment (ISTp) has been proposed as an alternative. The objective of this study was to explore the acceptability of ISTp for health workers and pregnant women. METHODS: Semi-structured interviews of ten health workers and five focus group discussions of 38 women enrolled in an ongoing trial comparing IPTp-SP and ISTp with dihydroartemisinin–piperaquine (DP) were conducted at two antenatal clinics in rural Malawi. All transcripts were coded and themes were identified using a content analysis approach. RESULTS: Amongst health workers, there were contrasting opinions on the preference of blood sampling methods, and the influence of method on reliability of diagnosis. The perceived greater effectiveness of DP compared to SP was appreciated, however concerns of user compliance with the full dose of DP in non-trial settings were raised. Despite the discomfort of repeated finger pricks, pregnant women were generally accepting of ISTp, particularly the chance for regular blood tests to check for infections and the perceived greater effectiveness with fewer side effects of DP compared to SP. CONCLUSION: In the trial context, pregnant women tended to prefer ISTp-DP over IPTp-SP. Health workers were also accepting of ISTp-DP as an alternative to IPTp-SP in light of increasing SP resistance. However, reliability of stock, adherence to malaria test results and user adherence to the full course of DP may present barriers to successful routine implementation. Effective communication with health workers and between health workers, pregnant women and their communities will be essential for the acceptability of focused antenatal care, including the best malaria control measures available. BioMed Central 2016-11-28 /pmc/articles/PMC5126811/ /pubmed/27894353 http://dx.doi.org/10.1186/s12936-016-1627-5 Text en © The Author(s) 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Almond, Deborah
Madanitsa, Mwayi
Mwapasa, Victor
Kalilani-Phiri, Linda
Webster, Jayne
ter Kuile, Feiko
Paintain, Lucy
Provider and user acceptability of intermittent screening and treatment for the control of malaria in pregnancy in Malawi
title Provider and user acceptability of intermittent screening and treatment for the control of malaria in pregnancy in Malawi
title_full Provider and user acceptability of intermittent screening and treatment for the control of malaria in pregnancy in Malawi
title_fullStr Provider and user acceptability of intermittent screening and treatment for the control of malaria in pregnancy in Malawi
title_full_unstemmed Provider and user acceptability of intermittent screening and treatment for the control of malaria in pregnancy in Malawi
title_short Provider and user acceptability of intermittent screening and treatment for the control of malaria in pregnancy in Malawi
title_sort provider and user acceptability of intermittent screening and treatment for the control of malaria in pregnancy in malawi
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5126811/
https://www.ncbi.nlm.nih.gov/pubmed/27894353
http://dx.doi.org/10.1186/s12936-016-1627-5
work_keys_str_mv AT almonddeborah provideranduseracceptabilityofintermittentscreeningandtreatmentforthecontrolofmalariainpregnancyinmalawi
AT madanitsamwayi provideranduseracceptabilityofintermittentscreeningandtreatmentforthecontrolofmalariainpregnancyinmalawi
AT mwapasavictor provideranduseracceptabilityofintermittentscreeningandtreatmentforthecontrolofmalariainpregnancyinmalawi
AT kalilaniphirilinda provideranduseracceptabilityofintermittentscreeningandtreatmentforthecontrolofmalariainpregnancyinmalawi
AT websterjayne provideranduseracceptabilityofintermittentscreeningandtreatmentforthecontrolofmalariainpregnancyinmalawi
AT terkuilefeiko provideranduseracceptabilityofintermittentscreeningandtreatmentforthecontrolofmalariainpregnancyinmalawi
AT paintainlucy provideranduseracceptabilityofintermittentscreeningandtreatmentforthecontrolofmalariainpregnancyinmalawi